文献速递关节外科

全膝关节置换术后延长机械压缩装置治疗联合预防性阿司匹林预防深静脉血栓的疗效:一项随机对照试验

Efficacy in Deep Vein Thrombosis Prevention With Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial.
PubMed 文献 · J Arthroplasty · 2016-12-23

研究纳入100例限制性止血带全膝关节置换患者,均接受阿司匹林325 mg每日两次共3周,随机分为仅住院期间使用机械压缩装置组与出院后在家延长使用至术后6周组。出院后机械压缩装置组深静脉血栓发生率为0%,住院组为23.1%(P < .001),所有深静脉血栓均在术后3个月时消退。

要点

  • 出院后延长使用机械压缩装置至术后6周组深静脉血栓发生率为0%,仅住院使用组为23.1%(P < .001)。
  • 出院后机械压缩装置组患者满意度为9.56(±0.82),住院组为8.50(±1.46)(P < .001)。
  • 所有深静脉血栓均在术后3个月时消退。

核心结论

  • 限制性止血带全膝关节置换患者早期活动、术后阿司匹林管理3周并延长机械压缩装置治疗至术后6周,其深静脉血栓预防效果优于仅住院期间接受机械压缩装置治疗的患者(P < .05)。
  • 阿司匹林联合延长使用机械压缩装置使无症状深静脉血栓发生率为0%,进一步验证了该预防方案在低深静脉血栓风险全膝关节置换患者中的价值。

研究设计与样本

  • 随机对照试验,纳入100例限制性止血带全膝关节置换患者,深静脉血栓风险管理采用阿司匹林325 mg每日两次共3周。
  • 患者随机分为住院期间仅使用机械压缩装置组或出院后在家延长使用至术后6周组。
  • 于术后第2天、术后14天及术后3个月完成下肢双功能静脉超声检查以确认治疗后无深静脉血栓。

主要发现

  • 出院后机械压缩装置治疗组深静脉血栓发生率为0%,住院机械压缩装置组为23.1%(P < .001)。
  • 所有深静脉血栓均在术后3个月时消退。
  • 患者满意度出院后机械压缩装置组为9.56(±0.82),住院机械压缩装置组为8.50(±1.46)(P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin at 325 mg twice daily is now included as a nationally approved venous thromboembolism (VTE) prophylaxis protocol for low-risk total knee arthroplasty (TKA) patients. The purpose of this study is to examine whether there is a difference in deep vein thrombosis (DVT) occurrence after a limited tourniquet TKA using aspirin-based prophylaxis with or without extended use of mechanical compression device (MCD) therapy. METHODS: One hundred limited tourniquet TKA patients, whose DVT risk was managed with aspirin 325 mg twice daily for 3 weeks, were randomized to either using an MCD during hospitalization only or extended use at home up to 6 weeks postoperatively. Lower extremity duplex venous ultrasonography (LEDVU) was completed on the second postoperative day, 14 days postoperatively, and at 3 months postoperatively to confirm the absence of DVT after treatment. RESULTS: The DVT rate for the postdischarge MCD therapy group was 0% and 23.1% for the inpatient MCD group (P < .001). All DVTs resolved by 3 months postoperatively. Patient satisfaction was 9.56 (±0.82) for postdischarge MCD patients vs 8.50 (±1.46) for inpatient MCD patients (P < .001). CONCLUSION: Limited tourniquet TKA patients who were mobilized early, managed with aspirin for 3 weeks postoperatively, and on MCD therapy for up to 6 weeks postoperatively experienced superior DVT prophylaxis than patients receiving MCD therapy only as an inpatient (P < .05). The 0% incidence of nonsymptomatic DVTs prevented by aspirin and extended-use MCD further validates this type of prophylaxis in low DVT risk TKA patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Snyder MA, Sympson AN, Scheuerman CM, et al. Efficacy in Deep Vein Thrombosis Prevention With Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial. J Arthroplasty. 2016. PMID: 28159420. doi:10.1016/j.arth.2016.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。